K36 Therapeutics, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
K36 Therapeutics, Inc. is a biotechnology research company focused on translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics. Based in Cambridge, Massachusetts, the organization operates within the biotechnology research sector and is positioned to develop novel cancer-focused treatments. The company describes its work as translating epigenetic insights into therapeutic candidates, with a target of addressing oncogenic pathways through small molecules. Its size falls within a mid-range for biotech startups, reflecting a specialized team pursuing research and development in this niche. The most recent external developments indicate ongoing activity in the broader link-in-bio and technology ecosystem surrounding Linktree-related platforms, reflecting adjacent market dynamics rather than direct company operations.